Quarter Financials
Sorrento Therapeutics, Inc. (SRNE)
$0.3073
0.00 (0.00%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2023 Q2
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
|---|
| Net Income | -95 | -154 | -209 | -91 | -220 | -41 | -145 | -120 |
|---|
| Dividend Paid | - | -14 | - | - | - | - | - | - |
|---|
| Retained Earnings | -2,194 | -2,099 | -1,959 | -1,736 | -1,646 | -1,427 | -1,387 | -1,242 |
|---|
|
Year
|
2023 Q2
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
|---|
| Capital Expenditure | - | -0 | -5 | -4 | -3 | -3 | -2 | -1 |
|---|
| Net PPE | 107 | 140 | 138 | 129 | 129 | 127 | 126 | 122 |
|---|
|
Year
|
2023 Q2
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
|---|
| New Purchases | - | - | - | - | - | - | - | - |
|---|
| Intangible and Goodwill | 53 | 80 | 80 | 81 | 80 | 80 | 80 | 80 |
|---|